Efficacy in vivo of a cancer therapy strategy combining HSV1716 mediated oncolysis with gene transfer and targeted radiotherapy

Annette Sorensen, Robert J. Mairs, Lynne Braidwood, Craig Joyce, Joe Conner, Sally Pimlott, S. Moira Brown, Marie Boyd

Research output: Contribution to journalConference Contribution

Abstract

Oncolytic herpes viruses have show promise for the treatment of cancer however it is unlikely that the optimal application of these viruses will be as single therapeutic agents. An alternative strategy would be to utilise these viruses to deliver therapeutic transgenes and enhance their tumour cell killing capacity.
Original languageEnglish
Pages (from-to)134-135
Number of pages2
JournalMutagenesis
Volume27
Issue number1
DOIs
Publication statusPublished - 2012
Event34th Annual Meeting of the United Kingdom Environmental Mutagen Society - Nottingham, United Kingdom
Duration: 29 Jun 20111 Jul 2011

    Fingerprint

Keywords

  • cancer therapy
  • oncolysis
  • gene transfer

Cite this